However, we did not observe a decrease in the same signaling targets upon pharmacological inhibition of Gαq in a non-Gαq-dependent cutaneous melanoma cell line, SKMEL-28 (Fig. S2E). The gene discussed is GNAQ; the disease is cutaneous melanoma.